Evidence map›Paper›PMID 35256358›Full record

ArticleBMJ case reports2022

Successful multidisciplinary management of an asymptomatic gastrosplenic fistula in a diffuse large B cell lymphoma patient.

Sarah Mansouri, Chadey Assane, Francois-Charles Malo

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sarah MansouriGeneral Surgery, University of Sherbrooke Faculty of Medicine and Health Sciences, Sherbrooke, Quebec, Canada.ORCID http://orcid.org/0000-0002-0034-8088
Chadey AssaneGeneral Surgery, University of Sherbrooke Faculty of Medicine and Health Sciences, Sherbrooke, Quebec, Canada.ORCID http://orcid.org/0000-0002-4180-1926
Francois-Charles MaloGeneral Surgery, University of Sherbrooke Faculty of Medicine and Health Sciences, Sherbrooke, Quebec, Canada francois-charles.malo@usherbrooke.ca.ORCID http://orcid.org/0000-0002-4876-7185
Université de Sherbrooke · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastrosplenic fistula is a rare and potentially fatal clinical entity unknown to most healthcare providers. Its diagnosis and management are challenging; and addressing it too late can have devastating consequences for patients. To increase awareness about this pathology, we hereby present a case of asymptomatic gastrosplenic fistula arising from a diffuse large B cell lymphoma in a 60-year-old Caucasian man with no significant medical history. The patient was successfully treated with open

Indexed as

FistulaLymphoma, Large B-Cell, DiffuseAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideDoxorubicinEtoposideHumansMaleMiddle AgedNeoplasm Recurrence, LocalPrednisoneRituximabSplenectomyVincristineCyclophosphamideDoxorubicinEtoposidePrednisoneRituximabVincristinechemotherapygastroenterologymalignant and benign haematologystomach wallsurgery

Identifiers

PMID35256358
PMCPMC8905921
OpenAlexW4220655337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.